Markus K. Muellner

1.2k total citations
15 papers, 833 citations indexed

About

Markus K. Muellner is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Markus K. Muellner has authored 15 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Physiology. Recurrent topics in Markus K. Muellner's work include Nitric Oxide and Endothelin Effects (3 papers), Sulfur Compounds in Biology (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Markus K. Muellner is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Sulfur Compounds in Biology (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Markus K. Muellner collaborates with scholars based in Austria, United Kingdom and United States. Markus K. Muellner's co-authors include Sebastian Nijman, Hilde Laggner, Markus Exner, Marcela Hermann, Bernhard Gmeiner, Stylianos Kapiotis, Harald Esterbauer, Iris Z. Uras, Sabine M. Schreier and Claudia Kerzendorfer and has published in prestigious journals such as Nature Communications, Nature Biotechnology and PLoS ONE.

In The Last Decade

Markus K. Muellner

15 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus K. Muellner Austria	11	474	227	139	83	78	15	833
Yoko Nemoto‐Sasaki Japan	18	615 1.3×	169 0.7×	149 1.1×	156 1.9×	95 1.2×	38	1.1k
Mithu Majumder United States	13	788 1.7×	167 0.7×	54 0.4×	76 0.9×	116 1.5×	15	1.1k
Astrid Fauster Austria	8	764 1.6×	109 0.5×	104 0.7×	100 1.2×	95 1.2×	9	1.1k
Vishva M. Sharma United States	17	843 1.8×	147 0.6×	236 1.7×	229 2.8×	233 3.0×	26	1.4k
Juxiang Cao United States	12	750 1.6×	49 0.2×	178 1.3×	69 0.8×	86 1.1×	16	972
Karen W. Barbour United States	16	426 0.9×	46 0.2×	209 1.5×	51 0.6×	86 1.1×	30	721
Merja Auvinen Finland	9	821 1.7×	405 1.8×	106 0.8×	28 0.3×	65 0.8×	11	1.1k
Mel Silverman Canada	15	444 0.9×	55 0.2×	93 0.7×	90 1.1×	85 1.1×	29	736
Bei Zhen China	17	645 1.4×	34 0.1×	129 0.9×	106 1.3×	123 1.6×	21	1.2k
Shariff Bayoumy United States	10	810 1.7×	77 0.3×	86 0.6×	160 1.9×	87 1.1×	10	1.1k

Countries citing papers authored by Markus K. Muellner

Since Specialization

Citations

This map shows the geographic impact of Markus K. Muellner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus K. Muellner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus K. Muellner more than expected).

Fields of papers citing papers by Markus K. Muellner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus K. Muellner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus K. Muellner. The network helps show where Markus K. Muellner may publish in the future.

Co-authorship network of co-authors of Markus K. Muellner

This figure shows the co-authorship network connecting the top 25 collaborators of Markus K. Muellner. A scholar is included among the top collaborators of Markus K. Muellner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus K. Muellner. Markus K. Muellner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sridhar, R., et al.. (2022). Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System. Molecules. 27(23). 8119–8119. 7 indexed citations

Watt, Paul M., Vikrant Kumar, Kavitha Bharatham, et al.. (2021). Target identification for small-molecule discovery in the FOXO3a tumor-suppressor pathway using a biodiverse peptide library. Cell chemical biology. 28(11). 1602–1615.e9. 8 indexed citations

Mair, Barbara, Tomasz Konopka, Claudia Kerzendorfer, et al.. (2016). Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity. PLoS Genetics. 12(9). e1006279–e1006279. 35 indexed citations

Šmída, Michal, Ferran Fece de la Cruz, Claudia Kerzendorfer, et al.. (2016). MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated. Nature Communications. 7(1). 13701–13701. 33 indexed citations

Muellner, Markus K., Barbara Mair, Yasir H. Ibrahim, et al.. (2015). Targeting a cell state common to triple‐negative breast cancers. Molecular Systems Biology. 11(2). 789–789. 23 indexed citations

Inglés‐Prieto, Álvaro, Eva Reichhart, Markus K. Muellner, et al.. (2015). Light-assisted small-molecule screening against protein kinases. Nature Chemical Biology. 11(12). 952–954. 43 indexed citations

Muellner, Markus K., Claudia Kerzendorfer, Iris Z. Uras, et al.. (2014). TOPS: a versatile software tool for statistical analysis and visualization of combinatorial gene-gene and gene-drug interaction screens. BMC Bioinformatics. 15(1). 98–98. 5 indexed citations

Schneller, Doris, Georg Machat, Verena Proell, et al.. (2011). p19ARF/p14ARF controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma. Hepatology. 54(1). 164–172. 40 indexed citations

Carette, Jan E., Carla P. Guimarães, Irene Wuethrich, et al.. (2011). Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nature Biotechnology. 29(6). 542–546. 173 indexed citations

10.

Muellner, Markus K., Iris Z. Uras, Bianca V. Gapp, et al.. (2011). A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nature Chemical Biology. 7(11). 787–793. 134 indexed citations

11.

Muellner, Markus K., Sabine M. Schreier, Peter Quehenberger, et al.. (2010). Vitamin C inhibits NO-induced stabilization of HIF-1α in HUVECs. Free Radical Research. 44(7). 783–791. 6 indexed citations

12.

Muellner, Markus K., Ilse Schwarzinger, Mathew A. Sloane, et al.. (2009). Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis. PLoS ONE. 4(12). e8292–e8292. 64 indexed citations

13.

Schreier, Sabine M., Markus K. Muellner, Hannes Steinkellner, et al.. (2009). Hydrogen Sulfide Scavenges the Cytotoxic Lipid Oxidation Product 4-HNE. Neurotoxicity Research. 17(3). 249–256. 64 indexed citations

14.

Laggner, Hilde, Marcela Hermann, Harald Esterbauer, et al.. (2007). The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. Journal of Hypertension. 25(10). 2100–2104. 108 indexed citations

15.

Laggner, Hilde, Markus K. Muellner, Sabine M. Schreier, et al.. (2007). Hydrogen sulphide: A novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radical Research. 41(7). 741–747. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact